OncoLink Cancer Treatment and Resources
OncoLink Cancer Treatment and Resources

PSA Level after Radiation

Last Modified: November 5, 2006

Question

Dear OncoLink "Ask The Experts,"

In June 2003, I finished receiving IMRT for prostate cancer. My PSA readings since then fluctuate between 0.5-2.0, but go up and down, not a consistent rise in the level. My pretreatment PSA was 3.1. I assume from the readings that the cancer has not been eradicated. Can you give me your judgment on how serious my situation is, and what steps, if any, you would suggest? Thank you.

Answer

Richard Whittington, MD, Associate Professor of Radiation Oncology at the University of Pennsylvania School of Medicine, responds:

Serum PSA level is a sensitive tool for diagnosing prostate cancer, but less sensitive at following prostate cancer after radiation treatment. In fact, a number of conditions can make the PSA level rise. The most common besides tumor are prostate infection (I have seen PSA 's over 50 in young men with gonorrhea), trauma (PSA can go up, although not by much, after riding a bicycle and sitting in the seat) and ischemia (lack of oxygen caused by decreased or blocked blood flow, thought to be the mechanism for the PSA bounce that is seen after brachytherapy).

Keep in mind that the normal prostate gland produces PSA, it's just that less of it is leaked into the blood than when there is prostate cancer. After radiation, the free- PSA is not helpful because the radiated gland leaks PSA just like cancer. So, unlike a post-prostatectomy PSA, the result after radiation is not usually zero. I would suggest watching the value and not worrying until the PSA gets to 3. Although, in the case described above, the tumor did not make much PSA initially (given his pre-treatment PSA of 3.0), so it may be difficult to distinguish what's normal and what represents disease recurrence.

OncoLink I wish u knew...

Dr. Lin discusses head and neck cancer treatment, the potential side effects and the importance of being prepared and treated for them. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS